Table 3.
Effect on cell viability (%) of five plant extracts with L. buchneri on HaCaT keratinocytes.
| Concentration (μg/mL) | Cell Viability (%) | ||||
|---|---|---|---|---|---|
| TAB | ASB | HTB | GMB | SSB | |
| 0 | 100.00 ± 5.20 | 100.00 ± 5.20 | 100.00 ± 5.20 | 100.00 ± 5.20 | 100.00 ± 5.20 |
| 6.25 | 98.51 ± 6.43 | 102.88 ± 4.37 | 105.22 ± 2.78 | 103.06 ± 5.58 | 103.04 ± 2.49 |
| 12.5 | 100.94 ± 1.98 | 109.41 ± 2.12 | 107.80 ± 4.49 | 105.16 ± 4.88 | 100.97 ± 4.14 |
| 25 | 111.01 ± 5.40 | 108.31 ± 5.44 | 105.55 ± 2.77 | 104.63 ± 0.84 | 94.57 ± 1.65 |
| 50 | 112.53 ± 7.18 * | 110.86 ± 3.26 | 102.79 ± 4.68 | 118.83 ± 0.84 *** | 99.15 ± 2.59 |
| 100 | 130.13 ± 3.97 *** | 112.18 ± 3.80 * | 105.64 ± 4.10 | 114.20 ± 2.89 *** | 103.94 ± 2.20 |
| 200 | 160.24 ± 5.86 *** | 111.35 ± 7.95 * | 115.44 ± 3.44 *** | 132.13 ± 2.51 *** | 102.28 ± 1.92 |
| 400 | 159.50 ± 1.37 *** | 126.46 ± 2.92 *** | 118.46 ± 0.84 *** | 146.48 ± 8.25 *** | 107.54 ± 1.85 * |
* p < 0.05, and *** p < 0.001 versus non-treated group.